| Kenneth L Hatch Dpm Pa | |
|
1831 Forest Dr, Suite C, Annapolis, MD 21401-4430 | |
| (410) 263-7093 | |
| (410) 263-7094 |
| Full Name | Kenneth L Hatch Dpm Pa |
|---|---|
| Type | Facility |
| Speciality | Podiatrist |
| Location | 1831 Forest Dr, Annapolis, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649499179 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 409 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kenneth L Hatch Dpm Pa 1831 Forest Dr, Suite C, Annapolis, MD 21401-4430 Ph: (410) 263-7093 | Kenneth L Hatch Dpm Pa 1831 Forest Dr, Suite C, Annapolis, MD 21401-4430 Ph: (410) 263-7093 |
News Archive
Exposure to hydraulic fracturing fluid in drinking water has been shown to increase the risk of respiratory problems, premature births, congenital heart defects, and other medical problems. But not all wells are created equal.
An analysis of quality of cardiac care following the public release of data on measures of care at hospitals in Ontario, Canada, did not result in significant systemwide improvement in hospitals' performance on most quality of care indicators, according to a study to be published in the December 2 issue of JAMA. The study is being released early online because of its presentation at an American Heart Association scientific conference.
Covidien plc today announced that its Board of Directors has declared an 11% increase in the quarterly dividend rate, from $0.18 per ordinary share to $0.20 per ordinary share.
Infinity Pharmaceuticals, Inc. today announced that enrollment is ongoing locally for a Phase 1b/2 clinical trial of IPI-926, Infinity's oral molecule that inhibits Smoothened, a key component of the Hedgehog pathway, in combination with Gemzar (gemicitabine) in patients with previously untreated, metastatic pancreatic cancer.
In conjunction with the Charing Cross International Symposium (CX34), which concludes today in London, Minneapolis-based Medtronic, Inc. announced its plans for the imminent start of the IN.PACT Global SFA clinical study, an international research program to evaluate the treatment of peripheral artery disease using the company's IN.PACT Admiral drug-eluting balloon.
› Verified 5 days ago
Dr. Tomika Coleman, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 49 Old Solomons Island Rd Ste 104, Annapolis, MD 21401 Phone: 443-531-1197 | |
Wayne K Knoll, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 128 Lubrono Dr, Suite 102, Annapolis, MD 21401 Phone: 410-535-0620 Fax: 410-535-0802 | |
Lyle T. Modlin, Dpm Pa Podiatrist Medicare: Medicare Enrolled Practice Location: 43 Old Solomons Island Rd, Suite 102, Annapolis, MD 21401 Phone: 410-263-3100 Fax: 410-263-7380 | |
James M Mckee, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 139 Old Solomons Island Road, Suite C, Annapolis, MD 21401 Phone: 410-224-4448 Fax: 443-949-9539 | |
Foot And Ankle Specialists Of The Mid-atlantic, Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 129 Lubrano Dr, Suite 303, Annapolis, MD 21401 Phone: 410-266-7575 Fax: 410-266-7366 | |
Dr. Courtney S Palmer, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 168 West St, Annapolis, MD 21401 Phone: 410-573-1111 Fax: 410-573-1377 | |
Dr. Eric Scott Harmelin, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2086 Generals Hwy, Suite 101, Annapolis, MD 21401 Phone: 410-266-7666 Fax: 410-266-7703 |